It’s also not some decades-long, unsolved medical mystery. But it is deadly. In fact, each year in the United States more than 2.8 million people acquire serious infections caused by antibiotic-resistant bacteria.1 What’s more, at least 35,000 people die because of antibiotic-resistant infections.2 The truth is, antibiotic overuse and resistance is a pervasive problem.
Perhaps you’ve already looked for ways to combat antibiotic resistance. You’re in good company: Healthcare leaders around the world are tackling the issue head-on with actionable steps, including antibiotic stewardship programs like the Core Elements from the Centers for Disease Control and Prevention (CDC). Such programs are designed to improve antibiotic prescribing and patient outcomes.
Procalcitonin (PCT) is a sensitive, specific, STAT biomarker that may already be part of your hospital’s existing system. The difference is in how and when you are using it, and if you can confidently interpret results to truly effect change across your organization.
Each year in the United States, at least 35,000 people die because of antibiotic-resistant infections.2
Pairing an antibiotic stewardship program with appropriate antibiotic prescribing and optimized PCT testing benefits not only current patients, but also the public at large and the bottom line. This is a call to action—you have a role to play, and the time to act is now.
This is a call to action—you have a role to play, and the time to act is now.